News & Updates

Treatment with degarelix results in a substantial reduction in bone mineral density (BMD) and an increase in bone turnover markers, reports a study.

PCSK9 inhibitors alirocumab and evolocumab are not only safe and well tolerated but also efficacious in Asian patients, results of a real-world study in Singapore have shown. However, about a third of patients stopped using these medications due to their high costs.

Peer victimization, or bullying, appears to be highly prevalent among youth, according to a recent Singapore study. In turn, bullying aggravates depressive symptoms and worsens quality of life.

Lower birthweight appears to carry an increased future risk of developing myocardial infarction (MI) and unhealthy left ventricular (LV) phenotypes, a study has found.

Results from the open-label extension (OLE) period of the phase II DUET trial demonstrated the long-term nephroprotective potential and safety of sparsentan for individuals with focal segmental glomerulosclerosis (FSGS).

Among patients with paroxysmal atrial fibrillation (AF), initial treatment with cryoballoon ablation reduced the incidence of persistent AF through 3 years of follow-up compared with antiarrhythmic drug (AAD) therapy, according to the PROGRESSIVE-AF* trial presented at AHA 2022.

Lower levels of zinc in hair may be a warning signal for psychosis among treatment-naïve adolescents, a study has found.